G-CSF treatment in mice with cardiac hypertrophy further markedly increased the number of CD45+ CD34+ VLA-4+ cells (3.4-fold; P < 0.01) and CD45+ CD34+ c-kit+ cells (2.8-fold; P < 0.05; Fig.1A and B). The gene discussed is PTPRC; the disease is cardiac hypertrophy.